Hypoglycemia in Hospitalized Patients

Phase

N/A

Condition

Diabetic Neuropathy

Hormone Deficiencies

Diabetic Vitreous Hemorrhage

Treatment

N/A

Clinical Study ID

NCT02228642

PRO14030372

Ages 18-90
All Genders

Study Summary

Patients with diabetes who develop low blood sugars (hypoglycemia) in the hospital are at risk for losing the ability to develop symptoms that warn them that they are having a low blood sugar. There is almost no available information investigating how the inability to feel symptoms of a low blood sugar contributes to the risk of this happening when people with diabetes are hospitalized. The purpose of this study is to develop a symptom score model that will help to identify patients at risk for low blood sugars in the hospital and to examine what happens to patients who do experience a low blood sugar in the hospital.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Diagnosis of diabetes
Non-critically ill hospitalized surgical and medical patients
Anticipated length of stay (LOS) >3 days
Anticipated life expectancy > 1 year
Mentally competent individuals

Exclusion

Exclusion Criteria:

Patients who are admitted for hypoglycemia or Diabetic Ketoacidosis
Anticipated LOS <3 days
Mentally incompetent individuals defined as any patient with evidence of dementia ordelirium recorded in their medical history or progress note
Patients receiving Total Parenteral Nutrition
Treatment with high dose narcotic medications
Patients who would not be able to follow up at 3 to 6 and 9-12 months by telephonecall
Patients with expected life expectancy < 1 year

Study Design

August 01, 2014

March 31, 2016

Study Description

Patients who develop recurrent hypoglycemia are predisposed to developing hypoglycemia-associated autonomic failure (HAAF, impaired awareness). There is almost no information investigating the contribution of HAAF as a risk factor for hypoglycemia in hospitalized patients. Our central aim is to develop a validated inpatient hypoglycemic symptom score model to examine HAAF and its correlation with cognitive dysfunction, re-hospitalization rates, inpatient morbidity and mortality.

This will be a prospective non-blinded study performed in a tertiary care center that will include non-critically insulin treated patients with Type 1 and 2 Diabetes. We will identify patients who have experienced moderate hypoglycemia (40-70 mg/dl) or severe hypoglycemia (< 40 mg/dl) within the prior 24 hours by daily generated computerized reports. Participants will be asked to complete a Hypoglycemia Symptom Scores Questionnaire and cognitive testing within 24-36 hours post event. Participants will be contacted at 6 and 12 months following the index hospitalization to obtain information regarding recurrent episodes of hypoglycemia, need for re-hospitalization, and occurrence of any new diabetes related complications.

Connect with a study center

University of Pittsburgh Medical Center PUH SSY
Pittsburgh, Pennsylvania 15213
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.